Trial in AML Secondary to MPNs Patients, Unfit for Intensive Chemotherapy, Investigating a Treatment Combination Including Decitabine and Venetoclax
Clinical trial NCT04763928 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04763928
- Sponsor
- Gruppo Italiano Malattie EMatologiche dell'Adulto
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-03
- Primary completion
- 2024-10-25
- Enrollment
- 101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.